AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06783257 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole sodium for injection
Description: 80mg，iv，30±3min； Followed by 8 mg/h, ivd, 71.5 h
Study NCT06786858 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HandMate
Description: HandMate device is used for 20 hours in 4 weeks. Device is then used in the home for 3 months at discretion of participant.
Study NCT06784219 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hindi version of self reported oral health questionnaire
Description: The original 8-item CDC/AAP questionnaire as well as other selected periodontal disease surveillance questions will be translated into Hindi through forward translation, backward translation, and expert committee process to reach a consensus and produce a prefinal version. The prefinal version questionnaire will be pilot tested on a sample of 20 patients to evaluate the overall comprehension by non-professionals. On the basis of responses and evaluation from the participants, the questionnaire will be further refined to build the final version. The final version of the questionnaire will be administered to patients seeking care from out-patient department of department of Periodontics at PGIDS, Rohtak. The participants will be required to fill the questionnaire by themselves prior to periodontal examination, without any help from others.
Study NCT05110365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation
Description: The patient will be provided with mild to moderate resistance PNF pattern which is a type of Endurance training which decreases BP through a reduction in systemic vascular resistance(15).In a regimen as follow with the frequency of 3 days a week, a repetition of 3 sets for one hour and a total duration of 3 months(16). The PNF patterns will be diagonal 1 (D1) and diagonal 2 (D2) patterns. Both patterns are subdivided into: A) Moving into Flexion: the toes start flexed and ends extended. Ankle and foot start plantar flexed; everted and ends dorsiflexed inverted. Tibia starts externally rotated and ends internally rotated. Knee starts extended, and ends flexed. The hip starts extended, abducted, internally rotated and ends flexed, adducted, externally rotated.B) Moving into Extension: The start and end are reversed to D1 Moving into Flexion
Study NCT05236855 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spectoscropy testing of urine specimen
Description: Urine samples will be independently tested by I R Spectroscopy and those results are to be compared with standard testing procedures for HPV
Study NCT06786559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assistive Device and health Education
Description: After discharge they will be assessed and followed by RA nurses through home visit and tele services for 2 months. The nurses will contact the patients periodically over telephone, and follow up their regular self-care activities, adjustment to devices, exercise and adaptive behavior.
Study NCT06782737 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietetic interventión with mediterranean diet
Description: Personalized dietary Mediterranean diet
Study NCT06786715 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Retrograde intrarenal surgery using DISS
Description: Retrograde intrarenal surgery using Direct in scope suction for renal stone up to 3 cm
Study NCT06786715 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Retrograde intrarenal surgery using FANS
Description: Retrograde intrarenal surgery using Flexible and navigable suction for renal stone up to 3 cm
Study NCT06787456 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EBV antibodies test
Description: ELISA test of VCA-IgA, EBNA1-IgA, EA-IgA, Zta-IgA, Rta-IgG and P85-Ab in nasopharyngeal brushing and plasma in plasma, saliva and nasopharyngeal brushing.
Study NCT06787456 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EBV DNA test
Description: quantitative polymerase chain reaction, methylation sequencing and target sequencing of EBV DNA in nasopharyngeal brushing, saliva and plasma.
Study NCT06787456 — intervention group
Intervention type: OTHER
Intervention: epidemiological information survey
Description: epidemiological information survey including basic conditions, dietary and lifestyle habits, social, geographical, environmental, and other information.
Study NCT06787456 — intervention group
Intervention type: OTHER
Intervention: Clinical examinations for high-risk participants
Description: nasopharyngoscopy, head and neck MRI.
Study NCT06787456 — intervention group
Intervention type: OTHER
Intervention: EBV and human genetic sequencing
Description: EB virus and human genetic sequencing for plasma, etc.
Study NCT04685421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine liposome
Description: Liposomal Bupivacaine PKs collections up to 96 hours on children from 2 to 17 years in pediatric cardiac surgeries.
Study NCT05006274 — intervention group
Intervention type: DEVICE
Intervention: Persona Trabecular Metal Tibia
Description: Total knee arthroplasty
Study NCT05006274 — intervention group
Intervention type: DEVICE
Intervention: Verasense technology
Description: Instrumented tibial trial component
Study NCT05006274 — intervention group
Intervention type: DEVICE
Intervention: MUVR
Description: Knee motion and gait sensing wearable device
Study NCT06517745 — intervention group
Intervention type: PROCEDURE
Intervention: Prone positioning
Description: Prone positioning sessions: at least one session per day proning duration: 2 hours at least per session
Study NCT06118463 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of serum AUNIP expression
Description: The experiment is carried out according to the ELISA kit instructions, and the absorbance optic density (OD) value of the enzyme labeler at 450 nm is read. The protein concentration of AUNIP in the serum sample is calculated according to the standard curve.
Study NCT05881031 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Initiation of NiPPV
Description: Initiation of NiPPV in the home environment through the utilization of an awake NiPPV titration, oximetries, and telemonitoring.
Study NCT06529159 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HEAPE
Description: The stomach is filled with sodium chloride solution which is then treated with APC to activate it into an antibacterial solution.
Study NCT06529159 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pre-HEAPE
Description: Plasma activated sodium chloride solution (prepared outside of the body) is administered into the patients stomach through an endoscope channel using a syringe.
Study NCT05400044 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Three dimensional maxillary bone augmentation
Description: mixing of bone marrow aspirate concentrate with xenograft to show the bone quality and bone gain compared to the xenografts mixed with autografts
Study NCT05400044 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Three dimensional maxillary bone augmentation
Description: mixing of bone marrow aspirate concentrate with xenograft to show the bone quality and bone gain compared to the xenografts mixed with autografts
Study NCT05006456 — intervention group
Intervention type: DEVICE
Intervention: Catheter ablation
Description: Subjects will undergo catheter ablation using the new technologies, including THERMOCOOL SMARTTOUCH® SF catheter with Visitag SURPOINT, QDOT catheter and HELIOSTAR catheter when they are used in conjunction with Carto system for AF ablations.
Study NCT05223803 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Prostate radiation (XRT)
Description: Both arms will receive prostate radiation. Multiple treatment regimens are allowed per protocol.
Study NCT05223803 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic Therapy
Description: All systemic therapy is provided as best prescribed for patient per their medical oncologist.
Study NCT05223803 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Stereotactic ablative radiation therapy (SABR)
Description: SABR is delivered to those randomized to Arm 2.
Study NCT05565820 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vamousse Spray 'n' Go
Description: Pediculicide for topical application, active ingredient Natrum Muriaticum 2X (HPUS).
Study NCT05565820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nix Creme Rinse Lice Treatment
Description: 1% permethrin lotion for topical application.
Study NCT06266988 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacubitril and Valsartan Tablets 97mg/103mg
Description: Each Tablet contains 97 mg of Sacubitril and 103 mg of Valsartan
Study NCT06266988 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entresto (Sacubitril and Valsartan Tablets 97mg/103mg)
Description: Each Tablet contains 97.2 mg sacubitril and 102.8 mg valsartan as sodium salt complex
Study NCT06786078 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lily Device
Description: Participants will wear the Lily Device at each chemotherapy session for the prescribed duration, where the device must be used during infusion and for at least two (2) hours and up to four (4) hours post infusion.
Study NCT06783478 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NK cell infusion
Description: Six infusions of 1 x 10⁷/kg of haploidentical NK cells, in vitro expanded and activated.
Study NCT06783478 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Six infusions of placebo
Study NCT06782893 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-pharmacological cough control therapy
Description: Over seven weeks (1 session per week, except session 5, which will be 2 weeks after session 4) using a one-on-one hybrid model. In session 1, participants will receive general education about chronic cough, introduction to cough suppression and goal setting. Session 2 will cover education about chronic cough in ILD, cough triggers and training in cough suppression techniques. Session 3 will focus on hydration techniques, laryngeal hygiene, and breathing exercises to control coughing. Session 4 will reinforce all aspects of non-pharmacological cough control treatment, and session 5 will explore the sustainability of cough control strategies after the program using real-life case scenarios.
Study NCT06782893 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Healthy lifestyle
Description: Over seven weeks (1 session per week, except session 5, which will be 2 weeks after session 4) using a one-on-one hybrid model. In session 1, participants will receive general education about exercise and physical activity. Session 2 will cover education about diet. Session 3 will focus on stress management. Session 4 will cover relaxation techniques, and session 5 will reinforce all aspects previously considered.
Study NCT06782061 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DSM17938+Routine clinical treatment
Description: Lactobacillus reuteri DSM17938，5 drops per day by mouth (containing at least 100 million CFU of Lactobacillus reuteri DSM17938)，Routine clinical treatment
Study NCT06045234 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urine sampling
Description: Among the 300 people recruited:~* 300 will each provide 3 urine samples collected on 3 different days during a week (e.g. Monday, Wednesday and Friday)~* 50 will each provide 3 urine samples collected at sunrise, in the middle and then at the end of the day over a period of 24 hours, on 3 different days during a week (e.g. Monday, Wednesday and Friday).
Study NCT06782945 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: BIOHM FX Probiotic Blend
Description: BIOHM Health has been selling BIOHM FX, a blend of probiotics as a dietary supplement addressed at the digestive health market since 2017. The blend is present in the market in various concentrations ranging from 30 Billion CFU to 1 Billion CFU. The probiotic blend consists of Lactobacillus acidophilus, Lactobacillus rhamnosus, Saccharomyces boulardii, Bifidobacterium breve and amylase. The blend is manufactured at cGMP facilities located in the United States and has attained self GRAS status. Prior to release, each lot of probiotic blend is tested for heavy metals, objectionable organisms, water content, probiotic potency, enzyme activity level and allergens, Soy, Milk and Gluten. Additionally, BIOHM performs annual testing for a full FALCPA panel of allergens ensuring there are no allergens present in the blend.
Study NCT06784245 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Synchronous telerehabilitation program
Description: About physiotherapy telerehabilitation sessions, few investigators have conducted well-designed investigations into whether patients achieve comparable benefit from in-clinic and remote physiotherapy services. Much of the research that exists implements a hybrid model of combined home and clinic sessions rather than just remote delivery (42). In this context, this study has been designed as a blinded (assessor and statistician), parallel group, randomized controlled trial (RCT) that aims to analyze the effectiveness of synchronous telerehabilitation on the physical condition, functional status, and quality of life of older people considers the disadvantages suggested by the literature and generates proposals in the study methodology to counteract them.
Study NCT06784245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Synchronous telerehabilitation program
Description: About physiotherapy telerehabilitation sessions, few investigators have conducted well-designed investigations into whether patients achieve comparable benefit from in-clinic and remote physiotherapy services. Much of the research that exists implements a hybrid model of combined home and clinic sessions rather than just remote delivery (42). In this context, this study has been designed as a blinded (assessor and statistician), parallel group, randomized controlled trial (RCT) that aims to analyze the effectiveness of synchronous telerehabilitation on the physical condition, functional status, and quality of life of older people considers the disadvantages suggested by the literature and generates proposals in the study methodology to counteract them.
Study NCT05400980 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Urocross implant
Description: Urocross implant inserted via delivery catheter
Study NCT05400980 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: SHAM_COMPARATOR
Intervention: Sham-control
Description: Cystoscopy
Study NCT06294158 — intervention group
Intervention type: OTHER
Intervention: Brightness measurement
Description: Measurement of ambience brightness using lux meters
Study NCT06294158 — intervention group
Intervention type: OTHER
Intervention: Sound level measurement
Description: Measurement of ambience sound levels using sound level meters
Study NCT05205811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupropion
Description: Extended-release bupropion dosing (150 mg each morning days 1-3, then 300 mg/daily) for the remainder of the 7 weeks.
Study NCT05205811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zonisamide
Description: Zonisamide (100 mg/daily) for 7 weeks.
Study NCT05205811 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo bupropion
Description: Placebo bupropion for 7 weeks.
Study NCT05205811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo zonisamide
Description: Placebo zonisamide for 7 weeks.
Study NCT05205811 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo zonisamide
Description: Placebo zonisamide for 7 weeks.
Study NCT05205811 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-cigarette
Description: e-cigarette for ad libitum use for two weeks prior to complete switch day and for an additional 10 weeks.
Study NCT05205811 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: E-cigarette
Description: e-cigarette for ad libitum use for two weeks prior to complete switch day and for an additional 10 weeks.
Study NCT04840589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BET Bromodomain Inhibitor ZEN-3694
Description: Given PO
Study NCT04840589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo a biopsy
Study NCT04840589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04840589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo a CT scan
Study NCT04840589 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Given IV
Study NCT04840589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04840589 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT05296915 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tVNS
Description: An electric current with a frequency of 25 Hz (Figure 2) will be applied to the cymba conca of the left ear through a specific device (VITOS, Cerbomed, Germany; CE marking). The stimulation intensity will be customized between 0.1 and 5 mA according to the sensitivity threshold of each participant. Patients will be instructed to perform tVNS at home for 4 non-consecutive hours per day for 12 weeks, in accordance with the protocol reported in the literature for the treatment of major depression.
Study NCT05296915 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: The stimulation will be carried out with a TMS STM9000 system (Ates, Medica Device s.r.l., Italy) equipped with a 70 mm butterfly cooled coil. The stimulation protocol followed will be the one approved by the FDA for major depression, that is, a stimulation at the level of the left dorsolateral prefrontal cortex at an intensity equal to 120% of the motor threshold, at the frequency of 10hz. Each stimulation session will last 37.5 minutes, and will consist of 75 trains lasting 4 seconds, with a 26-second break between each train. During each session, a total of 3000 stimuli will be administered. The sessions will take place 5 days a week, from Monday to Friday, for 4 weeks, and for a total of 20 sessions of stimulation.
Study NCT05296915 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT-E
Description: Targeted cognitive-behavioral therapy following the CBT-E protocol (CG Fairburn - 2010. La terapia cognitivo-comportamentale dei disturbi dell'alimentazione. Firenze, Eclipsi; 2010.)
Study NCT06232083 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PLDR+Cardunizumab
Description: Application of PLDR external irradiation combined with Cardunizumab in recurrent cervical cancer
Study NCT05501691 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Laser Simulation
Study NCT05501691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 445 nm Diode Laser Wavelength
Description: The Axial Surface of Class V Cavity will be Irradiated Using a 445 nm Diode Laser Wavelength
Study NCT05501691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 660 nm Diode Laser Wavelength
Description: The Axial Surface of Class V Cavity will be Irradiated Using a 660 nm Diode Laser Wavelength
Study NCT05501691 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 970 nm Diode Laser Wavelength
Description: The Axial Surface of Class V Cavity will be Irradiated Using a 970 nm Diode Laser Wavelength
Study NCT06464328 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi Combined with Music Therapy Intervention
Description: Tai Chi combined with music therapy Intervention, the effect was achieved by replacing the school's physical education classes with Tai Chi of the researchers' choice, and then by playing music of the researchers' choice during class; twice a week for twelve weeks
Study NCT06464328 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music intervention only
Description: Music only (120-130 bpm) The effect was achieved by playing music selected by the researchers during originally physical education classes in school; twice a week for twelve weeks
Study NCT06464328 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tai Chi intervention only
Description: Tai Chi intervention only The effect was achieved by replacing the school's originally physical education classes with Tai Chi of the researchers' choice; twice a week for twelve weeks
Study NCT05899166 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic diet, food delivery and education
Description: Meals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
Study NCT05899166 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard diet, food delivery and education
Description: Meals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
Study NCT05412498 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BR-30
Description: Battle rope training exercises will be performed for 30 seconds and the training volume will be consisted of 1 repetition.
Study NCT05412498 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BR-45
Description: Battle rope training exercises will be performed for 45 seconds and the training volume will be consisted of 1 repetition.
Study NCT05487833 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: insulin
Description: 5% glucose in 0.9% NaCl with 4 IU of short acting insulin per 500 ml added, infused at a rate determined by the treating physician, treatment duration: 18 hours
Study NCT05487833 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: standard treatment
Description: infusion of a balanced solution, infused at a rate determined by the treating physician, treatment duration: 18 hours